United States · FDA National Drug Code directory
BUPROPION HYDROCHLORIDE (SR)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-878_a9b85841-5a69-4df1-a22d-3d4cf174e9a6
- Product NDC
- 69097-878
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion Hydrochloride
- Labeler
- Cipla USA Inc.,
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160725
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-02) · 69097-878-02
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-03) · 69097-878-03
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-07) · 69097-878-07
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-12) · 69097-878-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →